98%
921
2 minutes
20
The brain's resting-state energy consumption is expected to be mainly driven by spontaneous activity. In our previous work, we extracted a wide range of features from resting-state fMRI (rs-fMRI), and used them to predict [F]FDG PET SUVR as a proxy of glucose metabolism. Here, we expanded upon our previous effort by estimating [F]FDG kinetic parameters according to Sokoloff's model, i.e., (irreversible uptake rate), (delivery), (phosphorylation), in a large healthy control group. The parameters' spatial distribution was described at a high spatial resolution. We showed that while is the least redundant, there are relevant differences between and (occipital cortices, cerebellum and thalamus). Using multilevel modeling, we investigated how much of the regional variability of [F]FDG parameters could be explained by a combination of rs-fMRI variables only, or with the addition of cerebral blood flow (CBF) and metabolic rate of oxygen (CMRO), estimated from O PET data. We found that combining rs-fMRI and CMRO led to satisfactory prediction of individual variance (45%). Although more difficult to describe, and were both most sensitive to local rs-fMRI variables, while was sensitive to CMRO. This work represents the most comprehensive assessment to date of the complex functional and metabolic underpinnings of brain glucose consumption.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11482815 | PMC |
http://dx.doi.org/10.1101/2024.10.05.615717 | DOI Listing |
Alzheimers Dement
September 2025
Department of Psychiatry and The Behavioral Sciences, Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Introduction: Clinical Dementia Rating Sum of Boxes (CDR-SB) is a reliable and clinically meaningful composite for assessing treatment effects in Alzheimer's disease (AD) clinical trials. Small CDR-SB differences at the end of a trial often lead to controversy in deriving clinically meaningful interpretations.
Methods: We estimated progression-free time (PFT) participants remained at each 0.
Front Pharmacol
August 2025
Department of Ophthalmology, The Fourth People's Hospital of Shenyang Affiliated to China Medical University, Shenyang, China.
Curcumin, a natural polyphenolic compound derived from , has shown great potential in the prevention and treatment of chronic inflammatory diseases due to its significant antioxidant and anti-inflammatory properties. This article aims to systematically review the anti-inflammatory molecular mechanism, clinical application prospects and challenges of curcumin. By searching the databases of Web of Science, PubMed, Google Scholar and CNKI, and integrating the latest research progress, it was found that curcumin exerted its core anti-inflammatory effects mainly by inhibiting the activation of nuclear factor-κB (NF-κB) signaling pathway, regulating the mitogen-activated protein kinase extracellular signal-regulated kinase (ERK) phosphorylation cascade, and regulating the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway.
View Article and Find Full Text PDFNeurocrit Care
September 2025
Department of Rehabilitation, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Background: Traumatic brain injury (TBI) is a major life-threatening event. In addition to neurological deficits, it can lead to long-term impairments of cognitive function. The vagus nerve (VN) provides a direct communication conduit between the central nervous system and the periphery, and modulation of the inflammatory reflex via electrical stimulation of the vagus nerve (VNS) shows efficacy in ameliorating pathology in neurodegenerative diseases.
View Article and Find Full Text PDFAdv Healthc Mater
September 2025
Shanghai Key Laboratory of Flexible Medical Robotics, Tongren Hospital, Institute of Medical Robotics, Shanghai Jiao Tong University, 1111 XianXia Road, Shanghai, 200336, China.
Current clinical treatments for intervertebral disc (IVD) herniation (e.g., discectomy) often lead to re-herniation, and tissue engineering scaffolds for annulus fibrosus (AF) regeneration remain scarce, particularly those capable of mimicking the multilayered structure of native AF.
View Article and Find Full Text PDFMol Ther
September 2025
Sanofi Genomic Medicine Unit, Waltham, USA, 02451. Electronic address:
Tau reduction is a promising therapeutic approach with the potential to slow the progression of Alzheimer's disease. Here, we propose adeno-associated viral (AAV) delivery of an artificial miRNA (amiRNA) targeting the microtubule-associated protein tau (MAPT) mRNA for sustained tau reduction with a single therapeutic injection. Out of 22 initial designs, we identified potent, accurately processed, and highly specific amiRNA candidates.
View Article and Find Full Text PDF